TACSTD2 and neoplasm: This antibody component targets the human trophoblast cell-surface antigen 2 (Trop-2), enabling SN-38 to internalize and activate its anti-tumor actions.10, –12 SG is distinguished by its high specificity for Trop-2 with a drug-to-antibody ratio of 7.6:1.